MedTrace Logo

Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift

NCT01320514 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2011-03-22

No results posted yet for this study

Summary

The primary objective is to evaluate the safety and efficacy of Artiss (Fibrin Sealant) in reducing the incidence of early postoperative bruising and swelling.

Conditions

  • Compare Ecchymosis and Edema for Fibrin Sealant and no Fibrin Sealant

Interventions

DRUG

Fibrin Sealant (Artiss)

Sponsors & Collaborators

  • Baxter BioScience

    collaborator INDUSTRY

  • Nguyen, Davis B., M.D.

    lead INDIV

Principal Investigators

  • Davis B Nguyen, M.D. · Davis B Nguyen, M.D.

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01320514 on ClinicalTrials.gov